520 related articles for article (PubMed ID: 26586640)
1. Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway.
Chiu CY; Yang RS; Sheu ML; Chan DC; Yang TH; Tsai KS; Chiang CK; Liu SH
J Pathol; 2016 Feb; 238(3):470-82. PubMed ID: 26586640
[TBL] [Abstract][Full Text] [Related]
2. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of acrolein, a ubiquitous environmental toxicant, on muscle regeneration and mass.
Chen HJ; Wang CC; Chan DC; Chiu CY; Yang RS; Liu SH
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):165-176. PubMed ID: 30378754
[TBL] [Abstract][Full Text] [Related]
4. Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation.
Chiu HC; Chiu CY; Yang RS; Chan DC; Liu SH; Chiang CK
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):585-602. PubMed ID: 29512306
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products impair coronary artery BK channels via AMPK/Akt/FBXO32 signaling pathway.
Li XY; Qian LL; Wu Y; Zhang YM; Dang SP; Liu XY; Tang X; Lu CY; Wang RX
Diab Vasc Dis Res; 2023; 20(4):14791641231197107. PubMed ID: 37592725
[No Abstract] [Full Text] [Related]
6. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
7. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
Shiota C; Abe T; Kawai N; Ohno A; Teshima-Kondo S; Mori H; Terao J; Tanaka E; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):188-94. PubMed ID: 26052151
[TBL] [Abstract][Full Text] [Related]
8. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
10. Kampo formula hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang, TJ-41) ameliorates muscle atrophy by modulating atrogenes and AMPK in vivo and in vitro.
Yakabe M; Hosoi T; Sasakawa H; Akishita M; Ogawa S
BMC Complement Med Ther; 2022 Dec; 22(1):341. PubMed ID: 36578084
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
12. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
[TBL] [Abstract][Full Text] [Related]
13. Insulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes.
Deng HP; Chai JK; Shen CA; Zhang XB; Ma L; Sun TJ; Hu QG; Chi YF; Dong N
Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26193886
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
15. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
[TBL] [Abstract][Full Text] [Related]
16. Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway.
Lv X; Lv GH; Dai GY; Sun HM; Xu HQ
Chin J Nat Med; 2016 Nov; 14(11):844-855. PubMed ID: 27914528
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
18. Effects of mesenchymal stromal cells on type 1 diabetes mellitus rat muscles.
Sabadine MA; Russo TL; Luna GF; Oliveira Leal AM
Muscle Nerve; 2018 Oct; 58(4):583-591. PubMed ID: 30028527
[TBL] [Abstract][Full Text] [Related]
19. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
20. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
Kimura N; Kumamoto T; Oniki T; Nomura M; Nakamura K; Abe Y; Hazama Y; Ueyama H
Muscle Nerve; 2009 Apr; 39(4):521-8. PubMed ID: 19296457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
